Stock AnalizUfp Technologies Inc. UFPT
Medical/Dental Instruments · IPO 1993 · data as of November 13, 2026
Ufp Technologies Inc. (UFPT) is a healthcare company listed in the US with a market value of about $2.4B. In the twelve months to September 30, 2026 it had revenue of $650M and net income of $77M, a net margin of 11.8%.
Its overall Stock Analiz score is 2.8 out of 5 (average). The strongest part is financial health (5/5); the weakest is value (1/5).
Key numbers: a P/E of 31.1, a price to free cash flow of 37.2, 5-year revenue growth of 27% a year, a 5-year average ROIC of 12%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 57% below the current price.
Score: 2.8 / 5
Checks passed
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
- Profitable 5 years in a row
- ROE above 15%
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- Profit margin improving
- Strong R&D investment or growth above 20%
- 5-year average ROIC above 12%
- Pays a dividend
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $650M | $603M | $504M | $400M | $354M | $206M | $179M | $198M | $190M | $148M | $146M |
| Net income | $77M | $68M | $59M | $45M | $42M | $16M | $13M | $20M | $14M | $9M | $8M |
| Free cash flow | $64M | $92M | $57M | $31M | $4M | $9M | $21M | $25M | $16M | $7M | $2M |
| EPS (diluted) | $9.81 | $8.75 | $7.58 | $5.83 | $5.45 | $2.09 | $1.77 | $2.63 | $1.93 | $1.26 | $1.10 |
| Net margin | 11.8% | 11.3% | 11.7% | 11.2% | 11.8% | 7.7% | 7.4% | 10.0% | 7.5% | 6.2% | 5.5% |
| ROIC | — | 13.2% | 11.9% | 14.5% | 14.4% | 5.7% | 7.7% | 12.5% | 9.2% | 7.3% | 7.0% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 2 analysts is $357.50, 17% above the current price; targets range from $350.00 to $365.00; the consensus rating is “Buy”; expected EPS is $10.79 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Ufp Technologies’s P/E ratio?
About 31.1, based on the last twelve months of diluted earnings per share (forward P/E about 27.0).
Is Ufp Technologies stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 57% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Ufp Technologies pay a dividend?
Not currently.
Is Ufp Technologies a good stock to buy?
We do not give buy or sell advice. Ufp Technologies scores 2.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.